Ondansetron HCl 16 mg Oral Tablet
RxNorm 692695
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 692695 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: ondansetron HCl 16 mg Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCDPrescribable
Semantic Clinical Drug (SCD):
Ondansetron 16 mg Oral Tablet
(Atom ID: 12329326)
SYPrescribable
Synonym (SY):
Ondansetron (as ondansetron hydrochloride dihydrate) 16 mg Oral Tablet
(Atom ID: 3276694)
PSNPrescribable
Prescribable Name (PSN):
Ondansetron HCl 16 mg Oral Tablet
(Atom ID: 7739305)
Patient Education
Ondansetron
Ondansetron is used to prevent nausea and vomiting caused by cancer chemotherapy, radiation therapy, and surgery. Ondansetron is in a class of medications called serotonin 5-HT3 receptor antagonists. It works by blocking the action of serotonin, a natural substance that may cause nausea and vomiting.
[Learn More]
* Please review the disclaimer below.